申请人:MACIELAG Mark J.
公开号:US20090275594A1
公开(公告)日:2009-11-05
The present invention is directed to novel 3-hydrazone piperazinyl rifamycin derivatives, pharmaceutical compositions containing them and the use of said derivatives and pharmaceutical compositions as antimicrobial agents against pathogenic microorganisms, particularly against resistant microbes.
本发明涉及新型的3-腙基哌嗪基利福霉素衍生物,包含它们的药物组合物以及将这些衍生物和药物组合物用作抗病原微生物的抗菌剂,特别是对抗耐药微生物。